Concept
Gut epithelial barrier
4 studies
The gut epithelial barrier is the selective lining that keeps luminal microbes and products out of blood while allowing nutrient exchange—tracked clinically by tight-junction and translocation markers and shaped by the microbiota.
Students often treat “microbiome” and “barrier leak” as the same claim. Barrier integrity, community composition, and host metabolic disease are related but answer different questions.
Studies
4
Findings
3
4 supporting · 0 challenging · 3 qualifying citations
Open tensions
1
Currently
What we know
- Severe COVID tracks plasma markers of barrier leak and microbial translocation.
- Antibiotics can perturb gut communities with host-cost consequences in model systems.
- Specific taxa and metabolite patterns associate with autoimmunity and metabolic syndrome risk contexts.
Largest unresolved question
Acute viral severity markers, antibiotic perturbation experiments, and chronic microbiota–disease associations should not be collapsed into one “leaky gut causes X” claim.
Common misconceptions
Any microbiome difference proves barrier failure.
Composition shifts and permeability/translocation markers are related but not interchangeable readouts.
Severe COVID gut signals prove that leak caused the severity.
Observational plasma associations cannot establish directionality.
Related
Claim ledger
What the evidence shows
Drawn from 4 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Severe COVID tracks plasma markers of barrier leak and microbial translocation.
Multi-omic plasma profiling linked severe COVID-19 to higher tight-junction permeability markers and bacterial/fungal product translocation versus milder disease/controls.
- Antibiotics hurt bee gut and survival— antibiotic–microbiota mortality work — not a COVID barrier assay
Study Role Design N Population Outcome Is severe COVID linked to leaky-gut plasma markers? Supports Cross-sectionalMulti-omic plasma comparison across COVID severity strata plus validation cohort N=80 · Main cohort: 60 COVID+ (20 mild/20 moderate/20 severe) + 20 negative controls; markers validated in additional samples Adults with mild–severe COVID-19 and SARS-CoV-2–negative controls (RUMC) Plasma gut-permeability and microbial translocation markers vs COVID severity Antibiotics hurt bee gut and survival Qualifiesantibiotic–microbiota mortality work — not a COVID barrier assay Animal / in-vitroWorker honeybees fed tetracycline; 16S community and survival vs germ-free controls Cup cages of 30 bees × 15 replicates per condition; 16S profiles n≈14–15 per arm — no single primary N Worker honeybees with conventional or germ-free guts Core gut microbiota disruption and mortality after tetracycline Antibiotics can perturb gut communities with host-cost consequences in model systems.
Antibiotic exposure perturbs gut microbiota and elevates mortality in the cited experimental setting—evidence that community disruption is not neutral for the host.
- Is severe COVID linked to leaky-gut plasma markers?— human COVID plasma markers ≠ mouse/antibiotic mortality design
Study Role Design N Population Outcome Antibiotics hurt bee gut and survival Supports Animal / in-vitroWorker honeybees fed tetracycline; 16S community and survival vs germ-free controls Cup cages of 30 bees × 15 replicates per condition; 16S profiles n≈14–15 per arm — no single primary N Worker honeybees with conventional or germ-free guts Core gut microbiota disruption and mortality after tetracycline Is severe COVID linked to leaky-gut plasma markers? Qualifieshuman COVID plasma markers ≠ mouse/antibiotic mortality design Cross-sectionalMulti-omic plasma comparison across COVID severity strata plus validation cohort N=80 · Main cohort: 60 COVID+ (20 mild/20 moderate/20 severe) + 20 negative controls; markers validated in additional samples Adults with mild–severe COVID-19 and SARS-CoV-2–negative controls (RUMC) Plasma gut-permeability and microbial translocation markers vs COVID severity Specific taxa and metabolite patterns associate with autoimmunity and metabolic syndrome risk contexts.
Bacteroides dorei dominance before autoimmunity and gut microbiota–metabolite links to metabolic syndrome show community composition correlating with host disease states beyond acute barrier leak.
- Is severe COVID linked to leaky-gut plasma markers?— chronic community associations ≠ acute COVID translocation markers
Study Role Design N Population Outcome B. dorei rises before T1D autoimmunity Supports CohortLongitudinal DIPP stool sequencing in HLA-risk children before T1D autoimmunity N=76 · 947 stool samples; 29 seroconverters vs 47 autoantibody-negative controls HLA-DQB1 moderate-to-high-risk children in DIPP Gut microbiota (B. dorei dominance) prior to persistent T1D autoantibodies Gut microbes, blood metabolites, and metabolic traits Supports Cross-sectionalMETSIM subset microbiome–metabolite–metabolic trait association analysis N=531 · 531 middle-aged Finnish men from the METSIM cohort (parent cohort 10,197) Middle-aged Finnish men in METSIM Associations of gut microbiota with plasma metabolites and metabolic traits Is severe COVID linked to leaky-gut plasma markers? Qualifieschronic community associations ≠ acute COVID translocation markers Cross-sectionalMulti-omic plasma comparison across COVID severity strata plus validation cohort N=80 · Main cohort: 60 COVID+ (20 mild/20 moderate/20 severe) + 20 negative controls; markers validated in additional samples Adults with mild–severe COVID-19 and SARS-CoV-2–negative controls (RUMC) Plasma gut-permeability and microbial translocation markers vs COVID severity
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
Acute viral severity markers, antibiotic perturbation experiments, and chronic microbiota–disease associations should not be collapsed into one “leaky gut causes X” claim.
Acute viral severity markers, antibiotic perturbation experiments, and chronic microbiota–disease associations should not be collapsed into one “leaky gut causes X” claim.
- Is severe COVID linked to leaky-gut plasma markers?
- Antibiotics hurt bee gut and survival
- B. dorei rises before T1D autoimmunity
- Gut microbes, blood metabolites, and metabolic traits
Study Role Design N Population Outcome Is severe COVID linked to leaky-gut plasma markers? Supports Cross-sectionalMulti-omic plasma comparison across COVID severity strata plus validation cohort N=80 · Main cohort: 60 COVID+ (20 mild/20 moderate/20 severe) + 20 negative controls; markers validated in additional samples Adults with mild–severe COVID-19 and SARS-CoV-2–negative controls (RUMC) Plasma barrier/translocation markers by COVID severity Antibiotics hurt bee gut and survival Supports Animal / in-vitroWorker honeybees fed tetracycline; 16S community and survival vs germ-free controls Cup cages of 30 bees × 15 replicates per condition; 16S profiles n≈14–15 per arm — no single primary N Worker honeybees with conventional or germ-free guts Antibiotic-perturbed microbiota and mortality B. dorei rises before T1D autoimmunity Supports CohortLongitudinal DIPP stool sequencing in HLA-risk children before T1D autoimmunity N=76 · 947 stool samples; 29 seroconverters vs 47 autoantibody-negative controls HLA-DQB1 moderate-to-high-risk children in DIPP Taxon dominance before autoimmunity Gut microbes, blood metabolites, and metabolic traits Supports Cross-sectionalMETSIM subset microbiome–metabolite–metabolic trait association analysis N=531 · 531 middle-aged Finnish men from the METSIM cohort (parent cohort 10,197) Middle-aged Finnish men in METSIM Microbiota–metabolite–metabolic syndrome links
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
Gut epithelial barrier
Concept page published
Gut epithelial barrier
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
- Coverage updated · Concept page published
Papers
4 studies in this library bear on Gut epithelial barrier, ordered by citations.
- Antibiotics hurt bee gut and survival
Tetracycline shrinks the honeybee gut microbiome and elevates mortality after hive return.
- Gut microbes, blood metabolites, and metabolic traits
In 531 METSIM men, gut microbiota associate with plasma metabolites and metabolic-syndrome-relevant traits.
- B. dorei rises before T1D autoimmunity
Bacteroides dorei dominates the gut microbiome before autoimmunity in high-risk Finnish children.
- Is severe COVID linked to leaky-gut plasma markers?
Severe COVID-19 showed higher tight-junction permeability and bacterial/fungal translocation markers that tracked systemic inflammation; zonulin was higher in patients who later died.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
Acute viral severity markers, antibiotic perturbation experiments, and chronic microbiota–disease associations should not be collapsed into one “leaky gut causes X” claim.
Ask PaperFren about Gut epithelial barrier
Study this conceptflashcards and short-answer questions
What plasma signals rose with severe COVID in the barrier study?
Tight-junction permeability and bacterial/fungal translocation markers.
Flashcards
0 of 1 answers reviewed